Diversion Control Division, US Department of Justice, Drug Enforcement Administration

ABOUT US > What's New

What's New

July

Final Rule: Controlled Substances Quotas (July 16, 2018)

Siegfried USA, LLC (July 16, 2018)

Cerilliant Corporation (July 16, 2018)

Temporary Scheduling Order: Temporary Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA Into Schedule I (July 10, 2018)

S & B Pharma, Inc. (July 5, 2018)

Ljudmil Kljusev, M.D.; Decision and Order (July 2, 2018)


June

Mohammed Asgar, M.D.; Decision and Order (June 25, 2018)

Kevin G. Morgan, RN/APN; Decision and Order (June 25, 2018)

Unither Manufacturing LLC (June 22, 2018)

Bulk Manufacturer of Controlled Substances Registration (June 20, 2018)

Fisher Clinical Services, Inc. (June 20, 2018)

American Radiolabeled Chem (June 20, 2018)

Cerilliant Corporation (June 20, 2018)

Importer of Controlled Substances Registration (June 15, 2018)

Notice of Intent: Temporary Placement of N-Ethylpentylone in Schedule I (June 13, 2018)

Importer of Controlled Substances Registration (June 13, 2018)

Alcami Wisconsin Corporation (June 13, 2018)

Johnson Matthey Pharmaceutical Materials Inc. (June 13, 2018)

Gazelle A. Craig, D.O.; Decision and Order (June 13, 2018)

Cambrex Charles City (June 13, 2018)

Bellwyck Clinical Services (June 13, 2018)

Restek Corporation (June 13, 2018)

60-Day Notice: The National Forensic Laboratory Information System Collection of Drug Analysis Data (June 11, 2018)

Richard Hauser, M.D.; Decision and Order (June 6, 2018)


May

Notice of Intent: Temporary Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA Into Schedule I (May 30, 2018)

Jopindar P. Harika, M.D.; Order (May 29, 2018)

Health Fit Pharmacy; Decision and Order (May 25, 2018)

DEA Internal Directive Regarding the Presence of Cannabinoids in Products and Materials Made from the Cannabis Plant (May 22, 2018)

Bulk Manufacturer of Controlled Substances Registration (May 15, 2018)

Patheon API Manufacturing, Inc. (May 15, 2018)

Donald Kenneth Shreves, D.V.M.; Dismissal of Proceeding (May 15, 2018)

Mylan Pharmaceuticals, Inc. (May 15, 2018)

Rhodes Technologies (May 15, 2018)

Xcelience (May 15, 2018)

Proposed Rule: Placement of beta-Hydroxythiofentanyl Into Schedule I (May 10, 2018)

Temporary Rule; Extension: Placement of beta-Hydroxythiofentanyl in Schedule I of the Controlled Substances Act (May 10, 2018)

William R. Montiel, M.D.; Decision and Order (May 8, 2018)


April

Garrett Howard Smith, M.D.; Decision and Order (April 30, 2018)

Cayman Chemical Company (April 23, 2018)

Final Order: Placement of Butyryl Fentanyl and U-47700 Into Schedule I (April 20, 2018)

Proposed Rule: Controlled Substances Quotas (April 19, 2018)

30-Day Notice: Application for Registration, Application for Registration Renewal; DEA Forms 363, 363a (April 17, 2018)

30-Day Notice: Application for Registration, Application for Registration Renewal, Affidavit for Chain Renewal; DEA Forms 225, 225a and 225b (April 17, 2018)

Clinical Supplies Management Holdings, Inc. (April 17, 2018)

Importer of Controlled Substances Registration (April 11, 2018)

Bulk Manufacturer of Controlled Substances Registration (April 11, 2018)

Witold Marek Zajewski, M.D.; Decision and Order (April 11, 2018)

Lipomed (April 11, 2018)

Almac Clinical Services Incorp (ACSI) (April 11, 2018)

United States Pharmacopeial Convention (April 9, 2018)

AMRI Rensselaer, Inc. (April 9, 2018)

Mehdi Nikparvarfard, M.D.; Decision and Order (April 4, 2018)

Catalent Pharma Solutions, LLC (April 4, 2018)

Wildlife Laboratories Inc. (April 4, 2018)

Bernard Wilberforce Shelton, M.D.; Decision and Order (April 2, 2018)

Angela L. Lorenzo, P.A.: Decision and Order (April 2, 2018)


March

Fisher Clinical Services, Inc. (March 29, 2018)

Lannett Company, Inc. (March 29, 2018)

Novitium Pharma, LLC (March 29, 2018)

Sharp Clinical Services, INC. (March 29, 2018)

Siegfried USA, LLC (March 29, 2018)

S&B Pharma, Inc. (March 29, 2018)

Chattem Chemicals, Inc.; Correction (March 29, 2018)

Navinta LLC (March 29, 2018)

Insys Manufacturing LLC (March 29, 2018)

National Center for Natural Products Research NIDA MPROJECT (March 29, 2018)

Synthcon, LLC (March 27, 2018)

Christopher D. Owens, M.D.: Decision and Order (March 27, 2018)

Keith F. Ostrosky, D.D.S.; Dismissal of Proceeding (March 21, 2018)

Sanyal Biotechnology LLC (March 21, 2018)

Noramco, Inc. (March 21, 2018)

Rhodes Technologies (March 21, 2018)

David A. Ruben, M.D.; Decision and Order (March 19, 2018)

Pharmacy Doctors Enterprises d/b/a Zion Clinic Pharmacy; Decision and Order (PDF) (March 13, 2018)

Temporary Scheduling Order: Temporary Placement of Seven Fentanyl-Related Substances in Schedule I; Correction (March 9, 2018)

Research Triangle Institute (March 9, 2018)

Stepan Company (March 5, 2018)

PerkinElmer, Inc. (March 5, 2018)

Stepan Company (March 2, 2018)


February

Mylan Pharmaceuticals Inc. (February 23, 2018)

60-Day Notice: Application for Registration, Application for Registration Renewal, Affidavit for Chain; Renewal DEA Forms 225, 225a and 225b (February 21, 2018)

60-Day Notice: Application for Registration, Application for Registration Renewal; DEA Forms 363, 363a (February 21, 2018)

Robert C. Vidaver, M.D.; Decision and Order (February 20, 2018)

James E. Ranochak, M.D.; Decision and Order (February 20, 2018)

Kenneth N. Woliner, M.D.; Decision and Order (February 20, 2018)

Trinity Pharmacy II; Decision and Order (February 20, 2018)

Johnson Matthey Inc. (February 20, 2018)

Taylor Animal Shelter; Order (February 20, 2018)

Trinity Pharmacy I; Order Terminating Registration (February 20, 2018)

Cerilliant Corporation (February 9, 2018)

INSYS Manufacturing LLC (February 9, 2018)

Mylan Pharmaceuticals, Inc. (February 9, 2018)

Noramco, Inc. (February 9, 2018)

Meridian Medical Technologies Inc. (February 9, 2018)

Johnson Matthey Inc. (February 9, 2018)

Mylan Technologies Inc. (February 9, 2018)

Noramco, Inc. (February 9, 2018)

AMRI Rensselaer, Inc. (February 9, 2018)

Siemens Healthcare Diagnostics Inc. (February 9, 2018)

Temporary Scheduling Order: Temporary Placement of Fentanyl-Related Substances in Schedule I (February 6, 2018)

Cedarburg Pharmaceuticals (February 6, 2018)

Patheon Pharmaceuticals, Inc. (February 6, 2018)

Chattem Chemicals, Inc. (February 6, 2018)

Temporary Scheduling Order: Temporary Placement of Seven Fentanyl-Related Substances in Schedule I (February 1, 2018)

Bulk Manufacturer of Controlled Substances Registration (February 1, 2018)

Importer of Controlled Substances Registration (February 1, 2018)

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility